FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1986579360> ?p ?o ?g. }

• W1986579360 endingPage "240" @default.
• W1986579360 startingPage "239" @default.
• W1986579360 abstract "There have been significant advancements in the care of patients with a hematological malignancy over the past 3 or more decades.1 Despite this, there still exists a significant mortality risk in curative treatment, and many patients with a hematological malignancy will die of their disease.1 A growing body of research indicates patients with a hematological malignancy do not receive best practice palliative and end-of-life care.2 Shortfalls in care include poor referral patterns to specialist palliative care services, lack of honest discussions regarding death and dying, inadequate spiritual care for patients and families, patients frequently dying in the acute care setting, and high levels of patient and family distress.2 There have been a number of efforts in the United Kingdom, United States, Sweden, and Australia demonstrating palliative and hematology care can coexist, exemplified through clinical case studies and innovative models of care.2 However, deficits in the provision of palliative care for patients with a hematological malignancy persist as evident in the international literature.2 Addressing this issue requires research exploring new aspects of a complex scenario; here we suggest priority areas of research. The Patient’s Voice While the experience of the bereaved caregiver and opinions of healthcare professionals have been explored,2 to the best of our knowledge the patient’s voice is missing in the literature. Published case studies demonstrate successful integration of palliative care when patients are provided with open, honest information and treatment options.3,4 It is acknowledged that research exploring the patient’s perspective in palliative care is difficult for ethical and practical reasons. However, patients with a hematological malignancy are often functionally well and physically able to participate in research despite having advanced disease, providing the opportunity for valuable insights to be shared even late in their illness trajectory. Revealing the patient’s voice is the next step forward in addressing the problem of inadequate palliative care provision for patients with a hematological malignancy. The Uniqueness of Hematology The unique nature and disease trajectory of patients with a hematological malignancy must be considered as these patients are much more likely to have fluctuating levels of health and to deteriorate rapidly to a terminal event than their solid tumor counterparts.2 It is argued that current models of specialist palliative care services and end-of-life care facilities are geared toward patients with solid tumors who experience a slower steady decline.1,5 Treatment that is viewed as “symptom management” by hematologists is often considered “active treatment” by palliative care physicians and is not facilitated in palliative care units.5 In light of these limitations, a formal study of how well specialist palliative care services can care for patients with a hematological malignancy is needed. Contribution of Cancer Nurses In response to increasingly complex healthcare systems, nursing roles are expanding and becoming more valuable in meeting the needs of specialized patient groups.6 Advanced practice nursing roles such as the role of nurse practitioner have great promise in improving holistic care and streamlining integration of palliative care, potentially resulting in improvements in symptoms, levels of emotional distress, and quality of life.6 However, much attention has focused on nursing competence in performing “medical tasks” such as bone marrow aspirates, insertion of central lines, and managing transfusions. The holistic model of nursing must not be undervalued or underutilized in advanced nursing roles. A high level of evidence supporting the effectiveness of these roles and models of care will be required. Cancer nurses can do more to improve palliative and end-of-life care provision for patients with a hematological malignancy. First, we need to help the patient’s voices be heard and understand their perspectives, perceptions, and understandings. This is certainly an exciting time for cancer nurses, as we have significant potential to improve the complex and unmet needs of patients with a hematological malignancy and help tailor palliative care to meet their specific needs. –Elise Button, MAdvPrac(Hons), BN, RN Raymond Javan Chan, PhD, MAppSc (Research) BN, RN, FACN Cancer Care Services, Royal Brisbane and Women’s Hospital, Herston, Queensland and School of Nursing and Midwifery Queensland University of Technology Brisbane, Australia" @default.
• W1986579360 created "2016-06-24" @default.
• W1986579360 creator A5042746473 @default.
• W1986579360 creator A5057882585 @default.
• W1986579360 date "2014-07-01" @default.
• W1986579360 modified "2023-09-27" @default.
• W1986579360 title "Palliative Care Provision for Patients With a Hematological Malignancy" @default.
• W1986579360 cites W1993921663 @default.
• W1986579360 cites W2051436682 @default.
• W1986579360 cites W2057923714 @default.
• W1986579360 cites W2078489550 @default.
• W1986579360 cites W2318138805 @default.
• W1986579360 doi "https://doi.org/10.1097/ncc.0000000000000164" @default.
• W1986579360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24933298" @default.
• W1986579360 hasPublicationYear "2014" @default.
• W1986579360 type Work @default.
• W1986579360 sameAs 1986579360 @default.
• W1986579360 citedByCount "6" @default.
• W1986579360 countsByYear W19865793602015 @default.
• W1986579360 countsByYear W19865793602016 @default.
• W1986579360 countsByYear W19865793602017 @default.
• W1986579360 countsByYear W19865793602018 @default.
• W1986579360 countsByYear W19865793602019 @default.
• W1986579360 crossrefType "journal-article" @default.
• W1986579360 hasAuthorship W1986579360A5042746473 @default.
• W1986579360 hasAuthorship W1986579360A5057882585 @default.
• W1986579360 hasBestOaLocation W19865793601 @default.
• W1986579360 hasConcept C126322002 @default.
• W1986579360 hasConcept C159110408 @default.
• W1986579360 hasConcept C177713679 @default.
• W1986579360 hasConcept C2779399171 @default.
• W1986579360 hasConcept C2909813644 @default.
• W1986579360 hasConcept C2909984355 @default.
• W1986579360 hasConcept C2994186709 @default.
• W1986579360 hasConcept C512399662 @default.
• W1986579360 hasConcept C71924100 @default.
• W1986579360 hasConceptScore W1986579360C126322002 @default.
• W1986579360 hasConceptScore W1986579360C159110408 @default.
• W1986579360 hasConceptScore W1986579360C177713679 @default.
• W1986579360 hasConceptScore W1986579360C2779399171 @default.
• W1986579360 hasConceptScore W1986579360C2909813644 @default.
• W1986579360 hasConceptScore W1986579360C2909984355 @default.
• W1986579360 hasConceptScore W1986579360C2994186709 @default.
• W1986579360 hasConceptScore W1986579360C512399662 @default.
• W1986579360 hasConceptScore W1986579360C71924100 @default.
• W1986579360 hasIssue "4" @default.
• W1986579360 hasLocation W19865793601 @default.
• W1986579360 hasLocation W19865793602 @default.
• W1986579360 hasLocation W19865793603 @default.
• W1986579360 hasOpenAccess W1986579360 @default.
• W1986579360 hasPrimaryLocation W19865793601 @default.
• W1986579360 hasRelatedWork W1980128108 @default.
• W1986579360 hasRelatedWork W2025807460 @default.
• W1986579360 hasRelatedWork W2063340637 @default.
• W1986579360 hasRelatedWork W2175332343 @default.
• W1986579360 hasRelatedWork W2347676151 @default.
• W1986579360 hasRelatedWork W2353170375 @default.
• W1986579360 hasRelatedWork W2361583949 @default.
• W1986579360 hasRelatedWork W2367127528 @default.
• W1986579360 hasRelatedWork W2378234934 @default.
• W1986579360 hasRelatedWork W2404070609 @default.
• W1986579360 hasVolume "37" @default.
• W1986579360 isParatext "false" @default.
• W1986579360 isRetracted "false" @default.
• W1986579360 magId "1986579360" @default.
• W1986579360 workType "article" @default.